Children with Down's syndrome display high rates of hyperuricaemia

Ayako Kashima1, Yukie Higashiyama, Masaru Kubota

  • 1Faculty of Human Life and Environment, Nara Women's University, Nara, Japan.

Insights

Hyperuricaemia (high uric acid) is common in children with Down syndrome, affecting 32.7% of patients. This early prevalence highlights the need for careful monitoring to prevent future health issues.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Genetic Diseases
  • Metabolic Disorders

Background:

  • Hyperuricaemia (high blood uric acid) is frequently observed in adults with Down syndrome.
  • Research on hyperuricaemia in pediatric Down syndrome populations is limited.
  • Understanding early prevalence is crucial for long-term health management.

Purpose of the Study:

  • To determine the prevalence of hyperuricaemia in children with Down syndrome.
  • To investigate associations between hyperuricaemia and lifestyle-related laboratory variables.
  • To explore the relationship with nutritional intake in this population.

Main Methods:

  • A comparative study involving 52 pediatric Down syndrome patients (ages 1-15) and age-matched controls.
  • Hyperuricaemia defined as uric acid z-scores > 2.0 based on pediatric reference values.
  • Nutritional intake assessed via 3-day dietary records.

Main Results:

  • Hyperuricaemia was found in 32.7% of Down syndrome patients, significantly higher than controls.
  • Prevalence was notably higher in males.
  • No significant differences in BMI, glucose, insulin, HOMA-IR, or purine intake; HDL cholesterol showed differences.

Conclusions:

  • High rates of hyperuricaemia are present from early childhood in Down syndrome patients.
  • This finding underscores the importance of proactive management in pediatric Down syndrome.
  • Hyperuricaemia is a potential independent risk factor for adult lifestyle-related diseases.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Karyotyping01:17

Karyotyping

Overview
49.3K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110